Trade Summary

1 week ago, Watanabe Todd, serving as See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,375 shares at $26.12 per share, for a total transaction value of $114,261.00. Following this transaction, Watanabe Todd now holds 717,203 shares of ARQT.

This sale represents a 0.61% decrease in Watanabe Todd's stake in the company.

The trade was executed on Monday, August 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 6, 2026 (accepted Aug 5, 9:42 PM ET), 3 days after the trade was made.

Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.